<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01810250</url>
  </required_header>
  <id_info>
    <org_study_id>EAGLE Registry</org_study_id>
    <nct_id>NCT01810250</nct_id>
  </id_info>
  <brief_title>Endurant for Challenging Anatomy: Global Experience Registry</brief_title>
  <acronym>EAGLE</acronym>
  <official_title>EVAR Treatment With the Endurant Stent Graft of Challenging Anatomy in Experienced Hands, the Real World Experience</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Catharina Ziekenhuis Eindhoven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Catharina Ziekenhuis Eindhoven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Department of Vascular Surgery at Catharina Hospital Eindhoven, The Netherlands initiates
      the Endurant for Challenging Anatomy: Global Experience (EAGLE) Registry. The aim of this
      study is to collect clinical information on the performance of the Endurant Stent Graft
      System for endovascular repair in anatomically challenging aneurysms, and to critically
      assess whether the current guidelines for anatomic eligibility to endovascular treatment with
      this system are still applicable. This study aims at creating a database that can be pooled/
      compared with the ENGAGE database.

      This study aims at answering two major questions:

        1. Is the technical success rate of successful delivery and deployment of the Endurant (II)
           similar in anatomically challenging aneurysm?

        2. Is the successful treatment rate comparable in anatomically challenging aneurysms, or
           does treatment of these aneurysms lead to more complications and reinterventions?
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Anticipated">May 2023</completion_date>
  <primary_completion_date type="Actual">January 2018</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>Clinical success</measure>
    <time_frame>12 months</time_frame>
    <description>Freedom from:
Increase of AAA diameter &gt; 5 mm (1 month measurement as baseline)
Type I&amp;III endoleaks
Aneurysm rupture
Conversion to surgery
Stent graft migration (&gt;10mm) resulting in SAE or reintervention
Stent graft occlusion</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Helath Related Quality of Life Scores</measure>
    <time_frame>12 months</time_frame>
    <description>EQ-5D VAS EQ-5D index</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">150</enrollment>
  <condition>Abdominal Aortic Aneurysms With Challenging Anatomy</condition>
  <arm_group>
    <arm_group_label>Abdominal Aortic Aneurysm (Challenging anatomy)</arm_group_label>
    <description>Endovascular aneurysm repair</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Endurant Stent Graft</intervention_name>
    <arm_group_label>Abdominal Aortic Aneurysm (Challenging anatomy)</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with abdominal aortic aneurysms (AAAs) with challenging anatomy defined by having
        one or more of the following measurements:

          -  Proximal necks 5 - 10mm in combination with &lt; 60 degrees infrarenal AND &lt; 45 degrees
             suprarenal angulation

          -  Proximal necks 10 - 15mm in combination with 60 degrees - 75 degrees infrarenal AND &lt;
             60 degrees suprarenal angulation OR in combination with &lt; 75 degrees infrarenal AND 45
             degrees - 60 degrees suprarenal angulation

          -  Proximal necks &gt; 15mm in combination with 75 degrees - 90 degrees infrarenal AND &lt; 75
             degrees suprarenal angulation OR in combination with &lt; 90 degrees infrarenal AND 60
             degrees - 75 degrees suprarenal angulation
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ≥ 18 years or minimum age as required by local regulations

          -  Indication for elective EVAR

          -  Challenging AAA anatomy

          -  Intention to electively implant the Endurant or Endurant II Stent Graft System©

          -  Signed informed consent form

        Exclusion Criteria:

          -  Subjects with intolerance to contrast media

          -  Chimneys or fenestrated device procedures

          -  High probability of non-adherence to physician's follow-up requirements

          -  Current participation in a concurrent trial that may confound study results
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Catharina Ziekenhuis</name>
      <address>
        <city>Eindhoven</city>
        <state>Noord-Brabant</state>
        <zip>5602 ZA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <link>
    <url>http://www.eagleregistry.nl</url>
    <description>Related info</description>
  </link>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 12, 2013</study_first_submitted>
  <study_first_submitted_qc>March 11, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 13, 2013</study_first_posted>
  <last_update_submitted>February 20, 2020</last_update_submitted>
  <last_update_submitted_qc>February 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Catharina Ziekenhuis Eindhoven</investigator_affiliation>
    <investigator_full_name>Joep Teijink</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm, Abdominal</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

